Search

everythinglearnresearchcommunity

for

Search:↓

Men with male pattern baldness have a higher risk of dying from prostate cancer.

Irregular menstrual cycles in teenagers are linked to a higher risk of polycystic ovary syndrome and metabolic syndrome.

Hair elemental analysis could be useful for health and exposure assessment but requires more standardization and research.

Children with classic congenital adrenal hyperplasia have thicker heart fat and are at higher risk for heart problems and early atherosclerosis.

A certain genetic variation is linked to a higher risk of polycystic ovarian syndrome.

A certain gene variation is linked to a higher risk of polycystic ovarian syndrome in South Indian women.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

High androgen levels in Chinese women with PCOS are linked to a higher risk of diabetes and obesity.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Heavy metals like arsenic, cadmium, and lead can increase cancer risk and worsen outcomes.

Insulin resistance in women with PCOS can lead to serious health issues, but lifestyle changes and certain medications can help manage symptoms.

Obesity worsens Polycystic Ovary Syndrome symptoms, and weight loss is a key treatment.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Hair loss can indicate brain aging and potential small vessel disease, but more research is needed to understand the clinical impact.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

Testosterone supplements can increase muscle mass and strength in older men with low levels, but long-term effects and risks need more research.

People with alopecia areata have higher insulin resistance.

Young men with early hair loss have slightly worse blood sugar and fat levels, suggesting possible health risks and need for monitoring.

People with hair loss have worse cholesterol levels, possibly linking hair loss to heart problems.

Early diagnosis and treatment of PCOS in young people is important to prevent long-term health problems.

The document concludes that personalized hormonal treatments are important for transgender individuals and more research is needed for non-binary treatments.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Evaluate postmenopausal women with high androgen levels using medical history, physical exams, lab tests, and imaging to manage health risks.

The document concludes that recognizing and properly diagnosing lipodystrophy syndromes is crucial for effective management and treatment.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.